Curative Biotechnology (CTYX) Stock Price, News & Analysis

Company Overview

Curative Biotechnology, Inc. engages in the provision of software solutions for the healthcare market. Its products include MedFlash, electronic Personal Health Manager, Medical Alert, personal emergency response services, product and medical transcription, disease management, revenue cycle management, and medical consulting-billing. The company was founded by Jon Pevzner on July 29, 1995 and is headquartered in Boca Raton, FL.

Key Stats

• Today's Range: $0.0089 to $0.01
• 50-Day Range: $0.0079 to $0.0149
• 52-Week Range: $0.00 to $0.22
• Volume: 13,850 shs
• Average Volume: 3.01 million shs
• Market Capitalization: $3.89 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CTYX Stock Analysis - Frequently Asked Questions

How have CTYX shares performed this year?

Curative Biotechnology's stock was trading at $0.0128 on January 1st, 2025. Since then, CTYX stock has decreased by 21.9% and is now trading at $0.01.

How do I buy shares of Curative Biotechnology?

Shares of CTYX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Curative Biotechnology own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Curative Biotechnology investors own include Universal Display (OLED), Curative Biotechnology (CUBT), Telenav (TNAV), Semiconductor Manufacturing International (SIUIF), Cellular Biomedicine Group (CBMG), ANADIGICS (ANAD) and Intec Pharma (NTEC).

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Business Services
• Industry: Miscellaneous Health & Allied Services
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:CTYX
• CIK: N/A
• Web: www.connectyx.com
• Phone: (561) 418-7725
• Fax: N/A
• Employees: 4
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 388,504,000
• Free Float: N/A
• Market Cap: $3.69 million
• Optionable: Not Optionable
• Beta: -33.99